Paragon 28 Analyst Ratings
Paragon 28 (FNA) Gets a Buy From Piper Sandler
Paragon 28 Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Zentalis Pharmaceuticals (ZNTL) and Paragon 28 (FNA)
Paragon 28's Sustained Growth and Strategic Initiatives Bolster Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
Maintaining a Buy: Paragon 28's Strong Q1 Performance and Optimistic Financial Outlook Despite CFO Transition
Paragon 28 Analyst Ratings
Analysts' Top Healthcare Picks: Paragon 28 (FNA), Genmab (GMAB)
Buy Rating Affirmed for Paragon 28 on Strategic Product Launches and Strong Market Position
Paragon 28 Analyst Ratings
Needham Reiterates Buy on Paragon 28, Maintains $17 Price Target
Paragon 28 Analyst Ratings
Piper Sandler Keeps Their Buy Rating on Paragon 28 (FNA)
Paragon 28 Analyst Ratings
Analysts Conflicted on These Healthcare Names: Paragon 28 (FNA) and Cooper Co (COO)
Buy Rating Affirmed: Paragon 28's Strong Q4 Performance and Promising 2024 Prospects
Analysts Offer Insights on Healthcare Companies: Paragon 28 (FNA), Intellia Therapeutics (NTLA) and Corcept Therapeutics (CORT)
No Data